Matthew K Szot Cadrenal Therapeutics, Inc. (CVKD) insider trading activity

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held N/A

Matthew K Szot Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2025	SELL Open market or private sale	$69,233 $6.97 p/Share	9,933 Reduced 100.0%	0 Common Stock
Oct 27 2025	SELL Open market or private sale	$25,182 $13.99 p/Share	1,800 Reduced 15.34%	9,933 Common Stock
Oct 24 2025	SELL Open market or private sale	$25,182 $13.99 p/Share	1,800 Reduced 13.3%	11,733 Common Stock
Oct 13 2025	SELL Open market or private sale	$25,326 $14.07 p/Share	1,800 Reduced 11.74%	13,533 Common Stock
Oct 09 2025	SELL Open market or private sale	$23,685 $13.99 p/Share	1,693 Reduced 9.94%	15,333 Common Stock
Oct 06 2025	SELL Open market or private sale	$1,496 $13.99 p/Share	107 Reduced 0.62%	17,026 Common Stock
Oct 01 2025	SELL Open market or private sale	$23,783 $13.99 p/Share	1,700 Reduced 9.03%	17,133 Common Stock

Sep 29 2025	SELL Open market or private sale	$1,400 $14.0 p/Share	100 Reduced 0.53%	18,833 Common Stock
Sep 25 2025	SELL Open market or private sale	$153,145 $14.05 p/Share	10,900 Reduced 36.54%	18,933 Common Stock
Sep 24 2025	SELL Open market or private sale	$21,000 $14.0 p/Share	1,500 Reduced 4.79%	29,833 Common Stock
Aug 28 2025	SELL Open market or private sale	$5,600 $14.0 p/Share	400 Reduced 1.26%	31,333 Common Stock
Aug 27 2025	SELL Open market or private sale	$22,384 $13.99 p/Share	1,600 Reduced 4.8%	31,733 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	50,000 Added 9.09%	500,000 Common Stock

SANW

S&W Seed Co Consumer Defensive

EVP Finance & Admin and CFO

INVO

INVO Bioscience, Inc. Healthcare

Director

SNES

SenesTech, Inc. Basic Materials

Director

MKS

Chief Financial Officer

Phoenix, AZ

Receive a notification when an Institution or Guru buys or sells CVKD shares.

Notify only if

Value

Get notified when an Cadrenal Therapeutics, Inc. insider buys or sells CVKD shares.

Notify only if

Operation

Value

Type

Receive news related to Cadrenal Therapeutics, Inc.